Akebia Therapeutics
AKBA
AKBA
166 hedge funds and large institutions have $448M invested in Akebia Therapeutics in 2018 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 73 increasing their positions, 24 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
166
Holders Change
+36
Holders Change %
+27.69%
% of All Funds
3.7%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
53
Increased
73
Reduced
24
Closed
16
Calls
$4.16M
Puts
$1.31M
Net Calls
+$2.85M
Net Calls Change
-$4.56M
Top Buyers
Top Sellers
| 1 |
1
Renaissance Technologies
New York
|
$0 |
| 2 |
2
Morgan Stanley
New York
|
$5.72M |
| 3 |
PA
3
Perceptive Advisors
New York
|
$9.18M |
| 4 |
MWNA
4
Marshall Wace North America
New York
|
$124K |
| 5 |
5
First Manhattan
New York
|
$1.44M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
176
Pacer Advisors
Malvern,
Pennsylvania
| – | -$43K | -4,856 | Closed |
|
|
IP
177
Isthmus Partners
Madison,
Wisconsin
| – | -$7K | -825 | Closed |
|
|
SPIA
178
Steward Partners Investment Advisory
New York
| – | -$7K | -800 | Closed |
|
|
SWP
179
Stratos Wealth Partners
Beachwood,
Ohio
| – | -$1K | -90 | Closed |
|